SMR Stemless Reverse vs SMR Reverse Shoulder System
NCT04697004
This study is recruiting at 7 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
The SMR Stemless Reverse is intended for total, primary shoulder joint replacement by reducing pain and restoring shoulder articular mobility function. This is a prospective, multi-center, randomized, controlled trial to demonstrate non-inferiority of the SMR Stemless Reverse to the SMR Reverse Shoulder System. Patients with joint dysfunction who continue to experience significant symptoms despite an appropriate course of non-operative management are eligible.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Arthroplasty, Replacement
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Limacorporate S.p.a
- Last updated on ClinicalTrials.gov
- October 28, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 3
- Levy Shoulder Center · Boca Raton, FL
- AdventHealth · Orlando, FL
- Foundation for Orthopaedic Research and Education · Tampa, FL
Indiana · 1
- Central Indiana Orthopedics · Fishers, IN
New York · 1
- Upstate Orthopedics · East Syracuse, NY
Pennsylvania · 2
- Rothman Orthopaedic · Philadelphia, PA
- Guthrie · Sayre, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.